Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites

Diabetologia

Volumn 50, Issue 10, 2007, Pages 2097-2106

  Weyrich, P ^a   Machicao, F ^a   Staiger, H ^a   Simon, P ^a   Thamer, C ^a   Machann, J ^a   Schick, F ^a   Guirguis, A ^a   Fritsche, A ^a   Stefan, N ^a   Haring H U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AMP protein kinase; AMPK; Insulin resistance; LDL cholesterol; PRKAG3; Single nucleotide polymorphism; SNP; Type 2 diabetes mellitus

Indexed keywords

AMP ACTIVATED PROTEIN KINASE GAMMA 3; APOLIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; GLYCOGEN MUSCLE LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

BLOOD GLUCOSE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS; LIVER; MULTIENZYME COMPLEXES; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 34548499864     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0788-8     Document Type: Article

References (39)

1. Winder WW, Hardie DG (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10
2. Steinberg GR, Macaulay SL, Febbraio MA, Kemp BE (2006) AMP-activated protein kinase-the fat controller of the energy railroad. Can J Physiol Pharmacol 84:655-665
3. Leff T (2003) AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31:224-227
4. Long YC, Zierath JR (2006) AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116:1776-1783
5. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
6. Schimmack G, Defronzo RA, Musi N (2006) AMP-activated protein kinase: role in metabolism and therapeutic implications. Diabetes Obes Metab 8:591-602
7. Wong KA, Lodish HF (2006) A revised model for AMP-activated protein kinase structure: The alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits. J Biol Chem 281:36434-36442
8. Mahlapuu M, Johansson C, Lindgren K et al (2004) Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am J Physiol Endocrinol Metab 286:E194-E200
9. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D (2000) Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346:659-669
10. Barnes BR, Long YC, Steiler TL et al (2005) Changes in exercise-induced gene expression in 5′-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice. Diabetes 54:3484-3489
11. Barnes BR, Marklund S, Steiler TL et al (2004) The 5′-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279:38441-38447
12. Sun MW, Lee JY, de Bakker PI et al (2006) Haplotype structures and large-scale association testing of the 5′ AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 with type 2 diabetes. Diabetes 55:849-855
13. Horikoshi M, Hara K, Ohashi J et al (2006) A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 55:919-923
14. Spencer-Jones NJ, Ge D, Snieder H et al (2006) AMP-kinase alpha2 subunit gene PRKAA2 variants are associated with total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women. J Med Genet 43:936-942
15. Xu M, Li X, Wang JG et al (2005) Glucose and lipid metabolism in relation to novel polymorphisms in the 5′-AMP-activated protein kinase gamma2 gene in Chinese. Mol Genet Metab 86:372-378
16. Daniel T, Carling D (2002) Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem 277:51017-51024
17. Burwinkel B, Scott JW, Buhrer C et al (2005) Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet 76:1034-1049
18. Arad M, Maron BJ, Gorham JM et al (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352:362-372
19. Gollob MH, Green MS, Tang AS et al (2001) Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344:1823-1831
20. Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119
21. Stefan N, Schafer S, Machicao F et al (2005) Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene. J Clin Endocrinol Metab 90:4238-4243
22. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553
23. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
24. Li SS, Khalid N, Carlson C, Zhao LP (2003) Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 4:513-522
25. Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: a java based linkage disequilibrium plotter. BMC Bioinformatics 7:60
26. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320
27. Milan D, Jeon JT, Looft C et al (2000) A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288:1248-1251
28. Barnes BR, Glund S, Long YC, Hjalm G, Andersson L, Zierath JR (2005) 5′-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 19:773-779
29. Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H (2001) Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. Diabetologia 44:824-833
30. Olofsson SO, Boren J (2005) Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J Intern Med 258:395-410
31. Soutar AK, Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214-225
32. Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J (2000) Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J 19:819-830
33. Hardie DG (1992) Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim Biophys Acta 1123:231-238
34. Omkumar RV, Darnay BG, Rodwell VW (1994) Modulation of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871. J Biol Chem 269:6810-6814
35. Sakai J, Rawson RB (2001) The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport. Curr Opin Lipidol 12:261-266
36. Nilsson EC, Long YC, Martinsson S et al (2006) Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice. J Biol Chem 281:7244-7252
37. Long YC, Barnes BR, Mahlapuu M et al (2005) Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia 48:2354-2364
38. Pittman RC, Attie AD, Carew TE, Steinberg D (1979) Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. Proc Natl Acad Sci USA 76:5345-5349
39. 14C]sucrose-labeled low density lipoprotein in rats. Contribution of receptor-dependent and receptor-independent pathways. J Biol Chem 257:8001-8008